I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
förra veckan
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
förra veckan
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
för 2 veckor sedan
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
för 2 veckor sedan
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
för 3 månader sedan
This too (and yh I DO wish I did this in CFD lol)
GGGGM
för 3 månader sedan
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
för 3 månader sedan
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
för 3 månader sedan
What do we think
At a loss now, watching a bit
GGGGM
för 3 månader sedan
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
för 3 månader sedan
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
för 3 månader sedan
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
för 3 månader sedan
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Denna sida kan innehålla användargenererat innehåll som Trading 212 inte ansvarar för. Skaffa alltid information på egen hand. Trading 212 är en execution only-tjänst, vilket innebär att Trading 212 inte erbjuder några investeringsråd eller någon portföljförvaltning.
Att bygga förmögenhet är en vana. Automatisera det med ett pie.
Investera i färdiga pies eller skapa ditt eget genom att välja bland tusentals aktier och ETF
Läs mer
Läs mer
Titta på videon
Förvärva även de dyraste aktierna som Google, Amazon och Apple.
Titta på videon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Se alla handelsinstrument
Support dygnet runt
29 sekunder genomsnittlig svarstid
Börja bygga rikedom nu
Bli en av över 5 miljoner användare
Hämta appen
Öppna konto
Skaffa mobilappen
Alla presenterade statistik är global. Antalet kunder representerar finansierade Konto.
Utmärkt
Betyg 4,6 / 5 baserat på 108 764 recensioner av
Trustpilot
Betyg 4,6 / 5 baserat på 108 764 recensioner av
Trustpilot
Inbjuden
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Inbjuden
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Inbjuden
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Inbjuden
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Inbjuden
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Inbjuden
How you rate the app
This app is so easy to use and safe really love it.
Inbjuden
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Inbjuden
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Inbjuden
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Inbjuden
Very good and informative always stay…
Very good and informative always stay on track with your investments
Inbjuden
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Inbjuden
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Inbjuden
Very easy app to register and use
Very easy app to register and use! Really pleased.
Inbjuden
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Inbjuden
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Inbjuden
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Inbjuden
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Inbjuden
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Inbjuden
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Inbjuden
Reliable
Reliable, Secure. Using it for past 3 years
Visa några av våra positiva kundrecensioner
Våra utmärkelser
Vanliga frågor och svar
Vad är aktiekursen för Capricor Therapeutics?
Det aktuella priset för Capricor Therapeutics är 7,59 $.
Vad är 52‑veckorshögsta för Capricor Therapeutics?
Högsta nivån på 52 veckor för Capricor Therapeutics är 40,37 $.
Vad är 52-veckorslägstanoteringen för Capricor Therapeutics?
Den lägsta nivån på 52 veckor för Capricor Therapeutics är 2,96 $.
Vad är den veckovisa prestandan för Capricor Therapeutics?
Under den senaste veckan har priset på Capricor Therapeutics ändrats med −20,36 %.
Hur ser den månatliga prestationen för Capricor Therapeutics ut?
Under den senaste månaden har priset på Capricor Therapeutics ändrats med 14,14 %.
Vad är 3-månadersprestandan för Capricor Therapeutics?
Under de senaste tre månaderna har priset på Capricor Therapeutics ändrats med −4,89 %.
Hur har 6‑månadersavkastningen för Capricor Therapeutics varit?
Under de senaste sex månaderna har priset på Capricor Therapeutics förändrats med −71,81 %.
Vad är den årliga prestandan för Capricor Therapeutics?
Under det senaste året har priset på Capricor Therapeutics förändrats med 31,54 %.